Efavirenz & Virologic failure

17.5%

of users reported Virologic failure

96.6%

also reported Severe reaction

55.3%

are men

Severe reaction

96.6%

Death

2.5%

Hospitalization

0.6%

Life-threatening condition

0.3%

Efavirenz: general information

10 - 19 years

1.3%

20 - 29 years

16.4%

30 - 39 years

31.0%

40 - 49 years

27.2%

50 - 59 years

23.1%

60 - 69 years

1.0%